The Extracellular Domain of Lrp5/6 Inhibits Noncanonical Wnt Signaling In Vivo

Vı́tězslav Bryja(Masaryk University), Emma Andersson(Karolinska Institutet), Alexandra Schambony(Karlsruhe Institute of Technology), Milan Ešner(Centre National de la Recherche Scientifique), Lenka Bryjová(Masaryk University), Kristin K. Biris(National Institutes of Health), Anita Hall(Karolinska Institutet), Bianca Kraft(Karlsruhe Institute of Technology), Lukáš Čajánek(Karolinska Institutet), Terry P. Yamaguchi(National Institutes of Health), Margaret Buckingham(Centre National de la Recherche Scientifique), Ernest Arenas(Karolinska Institutet)
Molecular Biology of the Cell
December 4, 2008
Cited by 110Open Access
Full Text

Abstract

Lrp5/6 are crucial coreceptors for Wnt/beta-catenin signaling, a pathway biochemically distinct from noncanonical Wnt signaling pathways. Here, we examined the possible participation of Lrp5/6 in noncanonical Wnt signaling. We found that Lrp6 physically interacts with Wnt5a, but that this does not lead to phosphorylation of Lrp6 or activation of the Wnt/beta-catenin pathway. Overexpression of Lrp6 blocks activation of the Wnt5a downstream target Rac1, and this effect is dependent on intact Lrp6 extracellular domains. These results suggested that the extracellular domain of Lrp6 inhibits noncanonical Wnt signaling in vitro. In vivo, Lrp6-/- mice exhibited exencephaly and a heart phenotype. Surprisingly, these defects were rescued by deletion of Wnt5a, indicating that the phenotypes resulted from noncanonical Wnt gain-of-function. Similarly, Lrp5 and Lrp6 antisense morpholino-treated Xenopus embryos exhibited convergent extension and heart phenotypes that were rescued by knockdown of noncanonical XWnt5a and XWnt11. Thus, we provide evidence that the extracellular domains of Lrp5/6 behave as physiologically relevant inhibitors of noncanonical Wnt signaling during Xenopus and mouse development in vivo.


Related Papers

No related papers found

Powered by citation graph analysis